Toagosei Co., Ltd. · TSE:4045
Toagosei — Q2 2020 Earnings Presentation
17 slides from Toagosei's earnings presentation, Aug 7, 2020
Slide 1: Financial Results for 2Q FY2020
Financial Results for 2Q FY2020 August 7, 2020 This document is a translation of the official Japanese version provided for information purpose only.
Slide 2: Overview of Results for 2nd Quarter of FY2020
Overview of Results for 2nd Quarter of FY2020 Scope of consolidation Number of consolidated subsidiaries: 19 (2 less than in FY2019. Liquidation of two logistics subsidiaries has been completed.) Number of equity-method affiliates: 2 (no change) 2019 2Q 2020 2Q Change (Millions of Net sales yen) 72,
Slide 3: Summary of Financial Results for 2nd Quarter of FY2020
Summary of Financial Results for 2nd Quarter of FY2020 <Business Environment> • Substantial slowdown in the global economy due to the impact of the spread of COVID-19 infection • Although the state of emergency declaration has been lifted, case numbers are climbing again, and there is no sign of the
Slide 4: Consolidated Results (by Segment)
Consolidated Results (by Segment) Net sales (by consolidated segment) (Millions of yen) Change in net sales 2019 2Q 2020 2Q Volume Unit price Change Commodity Chemicals 32,692 28,748 -2,673 -1,269 -3,943 Polymer & Oligomer 14,566 13,684 -733 -148 -881 Adhesive Material 5,475 4,849 -453 -173 -626 Per
Slide 5: Other Income/Expenses and Extraordinary Income/Loss (Consolidated)
Other Income/Expenses and Extraordinary Income/Loss (Consolidated) [Other income/expenses] [Extraordinary income/loss] (Millions of yen) (Millions of yen) 2019 2Q 2020 2Q Change 2019 2Q 2020 2Q Change Interest and dividend income 644 495 -148 Gain on sales of 3 - -3 non-current assets Equity in earn
Slide 6: Consolidated Balance Sheet
Consolidated Balance Sheet (Millions of yen) Dec. 31, Jun. 30, Change 2019 2020 Cash and deposits 32,989 40,013 7,023 [Balance Sheet] Notes and accounts receivable ① 42,534 37,396 -5,138 ① Notes and accounts receivable decreased Securities 44,000 35,000 -9,000 due to the decline in net sales ② The f
Slide 7: Overview of Consolidated Subsidiaries
Overview of Consolidated Subsidiaries (Results for 2nd Quarter of FY2020) (Millions of yen) Net income (loss) Ownership Net sales Operating income (loss) attributable to owners of Company name Segment (%) parent 2019/2Q 2020/2Q 2019/2Q 2020/2Q 2019/2Q 2020/2Q Commodity 1 Toa Techno-Gas Chemicals 100
Slide 8: Challenges in 2nd Half of FY2020
Challenges in 2nd Half of FY2020 Differences have emerged in the speed of each country’s recovery from the coronavirus crisis, while friction between the U.S. and China has intensified Uncertainty surrounds the future of measures to prevent the spread of infection in Japan, and measures designed to
Slide 9: Consolidated Results Forecast for FY2020
Consolidated Results Forecast for FY2020 (Millions of yen) FY2020 2H FY2020 forecast Change FY2019 (A) FY2020 1H (forecast) （B） （B-A） Net sales 144,955 65,775 68,225 134,000 -10,955 Operating income 13,782 5,665 6,335 12,000 -1,782 Operating income ratio 9.5% 8.6% 9.3% 9.0% -0.6% Other income/expens
Slide 10: Consolidated Results Forecast for FY2020 (by Segment)
Consolidated Results Forecast for FY2020 (by Segment) Net sales (Millions of yen) FY2019 FY2020 Change Factors for change results forecast Commodity Chemicals 65,667 58,100 -7,567 [Decrease] Acrylic monomer, caustic soda, industrial gases Polymer & [Decrease] Acrylic polymer, UV-curable resin, polym
Slide 11: Historical Consolidated Results
Historical Consolidated Results (Millions of yen) (Yen) 30,000 120 104.8 98.1 96.9 25,000 100 78.9 20,000 80 16,147(11.9%) 17,453(12.1%) 16,408(10.9%) 13,782(9.5%) 62.7 15,000 13,801 60 12,911 12,748 12,000(9.0%) 10,387 10,000 8,200 40 5,000 20 0 0 FY2016 FY2017 FY2018 FY2019 FY2020 (forecast) Opera
Slide 12: Reference for Consolidated Performance
Reference for Consolidated Performance (Billions of yen) FY2020 FY2016 FY2017 FY2018 FY2019 forecast Capital investment (acceptance basis) 5.1 10.0 12.5 15.8 14.1 Capital investment (approval basis) 13.2 22.1 17.0 16.9 13.8 Depreciation and amortization 7.9 7.9 8.3 9.2 9.9 Research and development e
Slide 13: Historical Reference for Consolidated Performance
Historical Reference for Consolidated Performance (Millions of yen) (Millions of yen) 200,000 50,000 193,764 195,015 186,419 182,624 40,000 78.5% 78.4% 167,991 76.5% 77.3% 30,000 76.8% 160,000 20,000 12,307 12,150 11,692 11,534 11,400 10,000 120,000 0 FY2016 FY2017 FY2018 FY2019 FY2020 (forecast) Sh
Slide 14: Medium-Term Operating Income Trend
Medium-Term Management Plan “Stage up for the Future” Operating Income Trend (Billions of yen) High-value-added products Commodity products 17.5 17.0 16.1 16.4 13.8 6.8 6.3 12.0 12.3 5.9 7.1 12.0 3.1 5.5 2.5 3.6 Commodity First products half: 2.0 4.5 10.2 10.7 3.9 10.7 8.4 9.2 9.3 High-value 8.3 -ad
Slide 15: Business Status (1)
Business Status (1) Polymer & Oligomer Segment Mass-production facilities commence operation using the new ester interchange production method for ARONIX We established a mass production system for this toluene- free, environmentally-friendly new product of outstanding potential, with high purity me
Slide 16: Business Status (2) Performance Chemicals Segment
Business Status (2) Performance Chemicals Segment Expanded and enhanced manufacturing facilities for inorganic functional materials Demand is increasing for antimicrobial and antivirus applications to combat the novel coronavirus infection. We have expanded and enhanced manufacturing facilities, wit
Slide 17: Business Status (3) Commodity Chemicals Segment
Business Status (3) Commodity Chemicals Segment Decided to establish a hydrogen station in Tokushima We support Tokushima Prefecture’s “hydrogen grid initiative,” and have decided to establish a hydrogen station on land adjoining the Tokushima Plant, in collaboration with Japan H2 Mobility, LLC, in